Sites Will Close Effective Today at 5 pm
FOR IMMEDIATE RELEASE
March 24, 2022
All Press Inquires to be Directed to:
Steve Vancore, (850) 528-4109
Tallahassee, FL – CDR Health has announced that their COVID-19 monoclonal antibody therapy sites across the State of Florida will close effective today, March 24, at 5 pm, due to the recent announcements regarding federal funding for COVID-19 running out. Without renewed funding by Congress, the company was also prompted to close its testing sites across the state last week—after spending two years on the front lines of COVID-19 in service of millions of Floridians.
“I am extremely proud of the CDR team, who has worked tirelessly since March 2020 to rapidly adapt to meet these healthcare challenges by combating the impact of COVID-19 on our communities in Florida,” said Tina Vidal-Duart, CDR Health CEO.
Since the beginning of the pandemic, CDR Health has provided over $500 million in goods and services—conducting over 18,000 mobile missions to deliver vaccinations to socially vulnerable and underserved communities, in addition to providing over 4 million COVID-19 tests, 2.7 million vaccinations, and 150,000 monoclonal antibody treatments.
“Unfortunately, without renewed funding, providing free mass monoclonal antibody treatment options to the public is not possible,” said Tina Vidal-Duart, CDR Health CEO. “However, if Congress passes a new funding bill that covers monoclonal antibody treatments, and/or other available sources of funding become available, CDR stands ready and willing to reopen sites within 24-48 hours.”
CDR Health’s Tallahassee Clinic in Leon County will continue to offer monoclonal antibody treatment options, in addition to COVID-19 testing and vaccinations—accepting in-network insurance or self-pay.
CDR Health is one of the leading COVID-19 monoclonal antibody treatment, testing, and vaccination providers on the front lines of the COVID-19 response. Their team has been advising multiple state and local governments since the beginning of the pandemic, providing valuable resources and supplies in response to COVID-19. CDR’s proprietary software, CDR HealthPro™, is designed to collect and keep track of patient data, integrating all patient, county, state, and federal needs into one streamlined portal. CDR Health has provided over 4 million COVID-19 tests, 2.7 million COVID-19 vaccinations, and 150,000 monoclonal antibody treatments.
